Dr Manrique Oscar Iriarte, MD - Medicare Internal Medicine in Miami, FL

Dr Manrique Oscar Iriarte, MD is a medicare enrolled "Internal Medicine" physician in Miami, Florida. His current practice location is 12750 Nw 17th St, Miami, Florida. You can reach out to his office (for appointments etc.) via phone at (305) 781-4815.

Dr Manrique Oscar Iriarte is licensed to practice in Florida (license number ME116904) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1003096587.

Contact Information

Dr Manrique Oscar Iriarte, MD
12750 Nw 17th St,
Miami, FL 33182-1420
(305) 781-4815
Not Available



Physician's Profile

Full NameDr Manrique Oscar Iriarte
GenderMale
SpecialityInternal Medicine
Location12750 Nw 17th St, Miami, Florida
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1003096587
  • Provider Enumeration Date: 11/13/2007
  • Last Update Date: 08/15/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 1052326170
  • Enrollment ID: I20131010000150

Medical Identifiers

Medical identifiers for Dr Manrique Oscar Iriarte such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003096587NPI-NPPES
109008600MedicaidFL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine ME116904 (Florida)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Manrique Oscar Iriarte allows following entities to bill medicare on his behalf.
Entity NameIriarte Primary Care Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922433739
PECOS PAC ID: 5991939753
Enrollment ID: O20131009001856

News Archive

Further delay in the trial of Dr. Jayant Patel

There is yet another delay in the Dr. Jayant Patel manslaughter trial. Justice John Byrne gave the jury a day off on Thursday agreeing to meet on Friday. He parted with encouraging words to the jury saying, "During the Second World War, so I'm told, at times when things were quiet for the soldiers, they were often encouraged with the words of (17th century poet John) Milton from three centuries earlier: `They also serve who only sit and wait'…I mention this because your involvement today now ceases and it will be not necessary for you to be involved in the trial for the rest of the day."

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

Platform therapeutic company Symic Biomedical, Inc. announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing hemodialysis.

Cervical cancer vaccine Gardasil can cause an allergic reaction

According to Australian researchers, the cervical cancer vaccine Gardasil can cause an allergic reaction in some girls.

Osiris Therapeutics' Prochymal granted FDA Orphan Drug Designation

Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.

Some diplomats, U.N. observers express 'concerns' over U.N. appeal for Haitian cholera aid, Al Jazeera reports

Following U.N. Secretary-General Ban Ki-moon's announcement on Tuesday of a new initiative appealing for $2.2 billion over 10 years to fight cholera in Haiti and the Dominican Republic, Al Jazeera reports "there are concerns by some diplomats and U.N. observers that the funds necessary for the program would not be forthcoming from donors."

Read more Medical News

› Verified 2 days ago

Entity NameUniversal Medical Group Of North Miami Beach Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1336515451
PECOS PAC ID: 6901135391
Enrollment ID: O20190910003228

News Archive

Further delay in the trial of Dr. Jayant Patel

There is yet another delay in the Dr. Jayant Patel manslaughter trial. Justice John Byrne gave the jury a day off on Thursday agreeing to meet on Friday. He parted with encouraging words to the jury saying, "During the Second World War, so I'm told, at times when things were quiet for the soldiers, they were often encouraged with the words of (17th century poet John) Milton from three centuries earlier: `They also serve who only sit and wait'…I mention this because your involvement today now ceases and it will be not necessary for you to be involved in the trial for the rest of the day."

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

Platform therapeutic company Symic Biomedical, Inc. announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing hemodialysis.

Cervical cancer vaccine Gardasil can cause an allergic reaction

According to Australian researchers, the cervical cancer vaccine Gardasil can cause an allergic reaction in some girls.

Osiris Therapeutics' Prochymal granted FDA Orphan Drug Designation

Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.

Some diplomats, U.N. observers express 'concerns' over U.N. appeal for Haitian cholera aid, Al Jazeera reports

Following U.N. Secretary-General Ban Ki-moon's announcement on Tuesday of a new initiative appealing for $2.2 billion over 10 years to fight cholera in Haiti and the Dominican Republic, Al Jazeera reports "there are concerns by some diplomats and U.N. observers that the funds necessary for the program would not be forthcoming from donors."

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Manrique Oscar Iriarte is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Manrique Oscar Iriarte, MD
429 Nw 130th Ave,
Miami, FL 33182-1143

Ph: (305) 781-4815
Dr Manrique Oscar Iriarte, MD
12750 Nw 17th St,
Miami, FL 33182-1420

Ph: (305) 781-4815

News Archive

Further delay in the trial of Dr. Jayant Patel

There is yet another delay in the Dr. Jayant Patel manslaughter trial. Justice John Byrne gave the jury a day off on Thursday agreeing to meet on Friday. He parted with encouraging words to the jury saying, "During the Second World War, so I'm told, at times when things were quiet for the soldiers, they were often encouraged with the words of (17th century poet John) Milton from three centuries earlier: `They also serve who only sit and wait'…I mention this because your involvement today now ceases and it will be not necessary for you to be involved in the trial for the rest of the day."

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

Platform therapeutic company Symic Biomedical, Inc. announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing hemodialysis.

Cervical cancer vaccine Gardasil can cause an allergic reaction

According to Australian researchers, the cervical cancer vaccine Gardasil can cause an allergic reaction in some girls.

Osiris Therapeutics' Prochymal granted FDA Orphan Drug Designation

Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.

Some diplomats, U.N. observers express 'concerns' over U.N. appeal for Haitian cholera aid, Al Jazeera reports

Following U.N. Secretary-General Ban Ki-moon's announcement on Tuesday of a new initiative appealing for $2.2 billion over 10 years to fight cholera in Haiti and the Dominican Republic, Al Jazeera reports "there are concerns by some diplomats and U.N. observers that the funds necessary for the program would not be forthcoming from donors."

Read more News

› Verified 2 days ago


Internal Medicine Doctors in Miami, FL

Dr. Rhea Bettina Sancassani, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1801 Nw 9th Ave Ste 209, Miami, FL 33136
Phone: 786-466-8490    Fax: 305-573-6562
Mrs. Dania M Verdecia, ARNP
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 11880 Bird Road, Suit 411, Miami, FL 33175
Phone: 305-223-1959    Fax: 305-220-7102
Jacklyn Reyes Pancrudo, D.O.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 11750 Sw 40th St, Miami, FL 33175
Phone: 561-997-0821    
Ms. Madeline De Los Milagros Castro, M.D.
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 971 Nw 2nd St, Miami, FL 33128
Phone: 305-545-7737    
Irwin Singer, M.D.
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1201 Nw 16th St, Miami, FL 33125
Phone: 305-575-3160    
Dr. Gianluca Iacobellis, M.D. PH.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1450 Nw 10th Ave, Miami, FL 33136
Phone: 305-243-3636    Fax: 305-243-6575

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.